Canonical ID: ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f · Entity type: Company (reference)
| Property | Value | Lang | Source dataset | Source ID | First seen | ||
|---|---|---|---|---|---|---|---|
Company:country | us | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:id | f8ef571e8468b7ce1a3602db9d55c0e5b95385ab | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:id | 1c263971bd790d45d370b9a6ac83cea63ca67aba | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:name | Johnson & Johnson | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:notes | Over the last three presidential administrations, the United States government has granted Johnson & Johnson 11 special licenses to do business in Iran. (New York Times, "Companies with Permission to Bypass Sanctions," 12/24/10) (http://www.nytimes.com/interactive/2010/12/24/world/24-sanctions-list.html) | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:sector | Pharmaceuticals* | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:sourceUrl | https://www.unitedagainstnucleariran.com/company/johnson-johnson | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:ticker | NYSE:JNJ | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:topics | export.risk | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||
Company:website | http://www.jnj.com/connect/ | ir_uani_business_registry | ir-br-co-b1a7ce55da1b14a641009515d3ff1b8cc694ae1f | ||||